These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1903100)

  • 21. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.
    Cooley TP; Kunches LM; Saunders CA; Ritter JK; Perkins CJ; McLaren C; McCaffrey RP; Liebman HA
    N Engl J Med; 1990 May; 322(19):1340-5. PubMed ID: 2139174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.
    Knupp CA; Brater DC; Relue J; Barbhaiya RH
    J Clin Pharmacol; 1993 Oct; 33(10):912-7. PubMed ID: 8227460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases.
    Klecker RW; Collins JM; Yarchoan R; Thomas R; Jenkins JF; Broder S; Myers CE
    Clin Pharmacol Ther; 1987 Apr; 41(4):407-12. PubMed ID: 3549120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.
    Seifert RD; Stewart MB; Sramek JJ; Conrad J; Kaul S; Cutler NR
    Br J Clin Pharmacol; 1994 Nov; 38(5):405-10. PubMed ID: 7893580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
    Kahn JO; Allan JD; Hodges TL; Kaplan LD; Arri CJ; Fitch HF; Izu AE; Mordenti J; Sherwin JE; Groopman JE
    Ann Intern Med; 1990 Feb; 112(4):254-61. PubMed ID: 2297204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.
    Singlas E; Taburet AM; Borsa Lebas F; Parent de Curzon O; Sobel A; Chauveau P; Viron B; al Khayat R; Poignet JL; Mignon F
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1519-24. PubMed ID: 1510449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.
    Balis FM; Pizzo PA; Butler KM; Hawkins ME; Brouwers P; Husson RN; Jacobsen F; Blaney SM; Gress J; Jarosinski P
    J Infect Dis; 1992 Jan; 165(1):99-104. PubMed ID: 1727902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
    Ray GF; Mason WD; Badr MZ
    Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection.
    Husson RN; Chung Y; Mordenti J; Butler KM; Chen S; Duliege AM; Brouwers P; Jarosinski P; Mueller BU; Ammann A
    J Pediatr; 1992 Oct; 121(4):627-33. PubMed ID: 1357124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina).
    Odinecs A; Pereira C; Nosbisch C; Unadkat JD
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2423-5. PubMed ID: 8891157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Didanosine.
    Shelton MJ; O'Donnell AM; Morse GD
    Ann Pharmacother; 1992 May; 26(5):660-70. PubMed ID: 1350471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of GLQ223 in rats, monkeys, and patients with AIDS or AIDS-related complex.
    Gatti G; Kahn JO; Lifson J; Williams R; Turin L; Volberding PA; Gambertoglio JG
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2531-7. PubMed ID: 1810186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team.
    Stevens RC; Rodman JH; Yong FH; Carey V; Knupp CA; Frenkel LM
    AIDS Res Hum Retroviruses; 2000 Mar; 16(5):415-21. PubMed ID: 10772527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center.
    Valentine FT; Seidlin M; Hochster H; Laverty M
    Rev Infect Dis; 1990; 12 Suppl 5():S534-9. PubMed ID: 1974725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Didanosine in the treatment of AIDS and AIDS-related complex: a critical appraisal of the dose and frequency of administration.
    Liebman HA; Cooley TP
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S52-8. PubMed ID: 8093847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifabutin absorption in the gut unaltered by concomitant administration of didanosine in AIDS patients.
    Li RC; Narang PK; Sahai J; Cameron W; Bianchine JR
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1566-70. PubMed ID: 9210686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.
    Balis FM; Pizzo PA; Eddy J; Wilfert C; McKinney R; Scott G; Murphy RF; Jarosinski PF; Falloon J; Poplack DG
    J Pediatr; 1989 May; 114(5):880-4. PubMed ID: 2715903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
    Dolin R; Lambert JS; Morse GD; Reichman RC; Plank CS; Reid J; Knupp C; McLaren C; Pettinelli C
    Rev Infect Dis; 1990; 12 Suppl 5():S540-9; discussion S549-51. PubMed ID: 1974726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.